| Invested through |
|
|---|---|
| Asset Classes | Corporate bonds |
| Impact strategy | Impact Equities and Bonds |
| ISIN code | XS2415468961 |
| Industry group | Health Care Equipment & Services |
| Aligned with SDGs |
Parnassia group is a Dutch mental health care company that provides services for prevention, treatment, support and care after treatment and relapse prevention in the Netherlands. Its regional focus is on the North-Holland, Haaglanden en Rijnmond. With 13,500 employees, the company offers its services as an extension of the general practitioner or at the client's home and has specialized brands that focus on e.g. child and youth psychiatry, drug abuse , forensic and intensive psychiatric care and intercultural psychiatry. Next to this the company is expanding in highly specialised mental care, such as complex anxiety, attention deficit disorders or therapy resistant depression.
Investment rationale
Mental health is recognized as a central piece for the full realization of the right to health by the UN and the WHO. Mental disorders are responsible for 30-40% of chronic sick leave in Western countries and cost around 3% of GDP. Mental health problems account for the major burden of disease in the Netherlands at 8.2%, higher than cardiovascular disease and cancer.
Parnassia group is the largest Dutch mental health service provider covering all age groups and mental disorders ranging from preventive care to treatment of psychological and psychiatric aspects of mental health. The company’s services are either covered by the public health insurance or are part of the services offered by municipalities or justice, making the services available to a large part of the Dutch population with varying mental disorders. Parnassia treats around 185,000 patients a year.